White Anti Cancer Drugs Sunitinib Malate CAS 341031-54-7 CP Grade

Anti-Cancer Drugs Sunitinib Malate CAS 341031-54-7 Sunitinib Malate Professional Supplier

Product Name: Sunitinib Malate
Synonyms: EZSolution Sunitinib Malate;Malic acid Shu;N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-2-hydroxybutanedioic acid (1:1) salt;SU 011248;SU112248;Sunitinib Malate(SU 11248);Butanedioic acid, 2;N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1
CAS: 341031-54-7
MF: C22H27FN4O2.C4H6O5
MW: 532.566
EINECS: 638-825-9
Melting point: 189-191°C
Storage temp.: Store at +4°C

Description:

Sunitinib malate is a kind of novel oral multi-targeted anticancer drugs and belongs to multi-targeted tyrosine kinase inhibitor with its trade name being "suntent". It was successfully developed by Pfizer Company and has dual anti-tumor effect. Moreover, it is the only therapeutic drug which can go beyond the 2-year survival period of advanced kidney cancer and plays a central role in the field of carcinoma and gastrointestinal stromal tumor therapeutic areas. It entered into market in February 2006 in the United States. This drug was the first anti-cancer drug which was approved by the US FDA and can simultaneously treat two diseases.

Usage:

Anti-cancer drugs